BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for Data-Cyte Plus 0,8 %, Medion Grifols Diagnostics AG

2014.01.16

Product group In-vitro diagnostics - haematological, histological and cytological products
Reference 07300/13

Corrective action from Grifols for Data-Cyte Plus 0,8 % due to falsely positive results. Customers were again informed about the problem.

Corrective action for Data-Cyte Plus 0,8 %, Medion Grifols Diagnostics AG , Download_VeroeffentlichtAm_EN PDF, 1MB, File does not meet accessibility standards